ArticleFrontiers in immunology2022

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma.

Xiaonan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.